Invenomic Capital Management’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-1,391,933
Closed -$13.1M – 140
2023
Q1
$13.1M Buy
1,391,933
+1,073,104
+337% +$12.7M 0.74% 45
2022
Q4
$3.9M Buy
318,829
+140,486
+79% +$1.75M 0.26% 99
2022
Q3
$2.21M Buy
+178,343
New +$3.12M 0.19% 116

Other funds holding ELAN

Invenomic Capital Management's ELAN Position: Q2 2023 in Review

Invenomic Capital Management sold out of Elanco Animal Health (ELAN) in Q2 2023, closing a stake of 1,391,933 shares — an estimated $13.1M sold.

Invenomic Capital Management first reported a position in ELAN in Q3 2022 and held it in 3 quarters. The position peaked at $13.1M in Q1 2023. 352 funds tracked by Wall St. Rank hold ELAN as of Q2 2023.

  • Invenomic Capital Management reported no remaining Elanco Animal Health position as of Q2 2023 after selling out during the quarter.
  • Invenomic Capital Management sold 1,391,933 Elanco Animal Health shares in Q2 2023, an estimated $13.1M.
  • Invenomic Capital Management first reported a position in Elanco Animal Health in Q3 2022 and held it in 3 quarters.
  • Invenomic Capital Management's Elanco Animal Health position peaked at $13.1M in Q1 2023.
  • 352 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2023.

Based on Invenomic Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.